Gynecologic Cancer
Conference Coverage
Cervical cancer rates fall, but other HPV cancers increase
Clinical Insights
The power and promise of social media in oncology
Dr. Alan Lyss describes a recent presentation on the role of social media in oncology.
Conference Coverage
For cervical cancer screening, any strategy is acceptable
Plus, an expert explains why increased rates of HPV vaccination may affect future screening guidelines.
Conference Coverage
Success in LGBTQ+ medicine requires awareness of risk
Cross-sex hormone therapy is a life-sustaining treatment that should be viewed analogously with any other long-term management strategy, such as...
From the Journals
Hyperprogression on immunotherapy: When outcomes are much worse
Opinion
Surgery for early-stage cervical cancer: Are we still too radical?
Radical vaginal or abdominal trachelectomy is associated with cancer recurrence rates of less than 5% and successful pregnancy in approximately...
News from the FDA/CDC
FDA approves new immunotherapy for endometrial cancer
The accelerated approval for dostarlimab is for use in patients with recurrent or advanced endometrial cancers with deficient mismatch repair.
Conference Coverage
Endometrial thickness could predict cancer, guide lymph node assessment
Patients with endometrial intraepithelial neoplasia don’t need routine lymph node sampling, an investigator says.
Commentary
How physicians can provide better care to transgender patients
Those transgender patients who seek care often have unpleasant experiences.
Clinical Insights
Steroid-refractory pneumonitis from ICIs: Experience at major centers
Feature
Cancer screening stopped by pandemic: Repercussions to come?